ZELTIQ® Showcases CoolAdvantage Petite™ Applicator for the CoolSculpting® System at American Academy of Dermatology Annua...
March 03 2017 - 9:00AM
ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology
company focused on developing and commercializing products
utilizing its proprietary controlled-cooling technology, today
announced it is showcasing the CoolAdvantage Petite™ applicator at
the American Academy of Dermatology Annual Meeting (AAD) in
Orlando, Fla. The CoolAdvantage technology is the only
non-invasive fat removal technology cleared by the Food and Drug
Administration (FDA) to address the upper arm.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/8d9d53d2-4730-40b2-bad3-d3560106fb41
http://www.globenewswire.com/NewsRoom/AttachmentNg/5f490a53-531c-4ac6-8c13-ff3a5c14d0d8
“After 5 years of research and millions of
dollars invested in development, we are proud to be the only
non-invasive fat reduction technology that is FDA-cleared to treat
the upper arms, the third greatest area of concern for consumers,”
said Mark Foley, President and Chief Executive Officer of
ZELTIQ. “Through direct-to-consumer advertising, we plan to
raise awareness around this new treatment area and help drive
consumers to our customers’ CoolSculpting practices.”
The newest member of the CoolAdvantage family of
applicators, the CoolAdvantage Petite, treats the upper arm in just
35 minutes and comes with two interchangeable contours customized
to treat the unique shape of the upper arm area. The
commercial release of the CoolAdvantage Petite applicator is
planned for the middle part of 2017.
“The upper arm, with its delicate structures, is
one of the most challenging areas for fat reduction,” said Jean
Carruthers, MD, FRCSC, FRC(OPHTH), of Carruthers & Humphrey
Cosmetic Dermatology in Vancouver, Canada. “As one of the
principal investigators for the CoolAdvantage Petite applicator, I
can attest to the fact that the upper arms responded beautifully
and my study patients are delighted by their results.”
Providers attending AAD who want to learn more about the
CoolSculpting procedure and CoolAdvantage Petite applicator can
visit CoolSculpting Booth #1231 in the Orange County Convention
Center during exhibit hours 10 a.m. to 5 p.m. March 3-4, and 10
a.m. to 3 p.m. on March 5. You can also learn more by
visiting www.coolsculptinghcp.com.
With more than 70 peer-reviewed clinical papers
and abstracts and over 4 million treatments performed to date in
over 80 countries around the world, CoolSculpting is clinically
proven to be a safe and effective treatment for non-invasive fat
reduction. CoolSculpting is FDA-cleared to affect the
appearance of fat bulges in the upper arm, bra and back fat, banana
roll, submental area, thigh, abdomen and flank.
CoolSculpting is available through an elite
network of CoolSculpting Centers worldwide. Dermatologists, plastic
surgeons and leading aesthetic specialists that offer CoolSculpting
can be found at www.coolsculpting.com.
About the CoolSculpting®
ProcedureCoolSculpting is a non-surgical, clinically
proven procedure that selectively reduces unwanted fat using a
patented cooling technology. Cleared by the FDA, CoolSculpting
works by gently cooling targeted fat cells to induce a natural,
controlled elimination of fat cells without affecting surrounding
tissue, and the treated fat cells are gone for good. Millions
of CoolSculpting treatments have been performed by more than 5,700
CoolSculpting systems in over 80 countries. Market research
indicates up to a 95 percent customer satisfaction rate with the
CoolSculpting procedure. CoolSculpting is available through an
elite network of CoolSculpting Centers worldwide. Dermatologists,
plastic surgeons and leading aesthetic specialists that offer
CoolSculpting can be found at www.coolsculpting.com.
Be sure to follow CoolSculpting
on Facebook, Twitter, Pinterest and YouTube.
About ZELTIQ® Aesthetics, Inc.ZELTIQ is a
medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ’s first
commercial product, the CoolSculpting system, is designed to
selectively reduce stubborn fat bulges. CoolSculpting is
based on the scientific principle that fat cells are more sensitive
to cold than the overlying skin and surrounding tissues. It
utilizes patented technology of precisely controlled cooling to
reduce the temperature of fat cells in the treated area, which is
intended to cause fat cell elimination through a natural biological
process known as apoptosis. ZELTIQ developed CoolSculpting to
safely, noticeably, and measurably reduce the fat layer.
Forward-Looking StatementsThe statements made
in this press release regarding ZELTIQ's expectations for
the performance of the CoolAdvantage Petite and its ability to
drive people to its customers’ practices to ask for CoolSculpting
by name are forward-looking statements. You should not place undue
reliance on these forward-looking statements because they involve
known and unknown risks, uncertainties and other factors that are,
in some cases, beyond ZELTIQ's control and that could
materially affect ZELTIQ's actual business operations.
Factors that could materially affect ZELTIQ's business
operations include, but are not limited to, risks and uncertainties
set forth in ZELTIQ's Quarterly Report on Form 10-Q for
the year ended December 31, 2016, filed with
the SEC on March 1, 2017. These forward-looking
statements speak only as of the date of this press
release. ZELTIQ expressly disclaims any obligation to
update information contained in these forward-looking statements
whether as a result of new information, future events or
otherwise.
MEDIA CONTACT:
Jill Knepper
Ketchum for ZELTIQ
310-437-2517
INVESTOR RELATIONS:
Taylor Harris
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico
The Ruth Group for ZELTIQ
646-536-7030
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024